Kyla Comins

Background

About Kyla Comins

I am a clinical investigator with experience in both industry clinical development trials targeting registration and academic clinical trials. I have several years' experience in the clinical management of primary healthcare patients, particularly those with HIV and associated opportunistic infections. My special interests over the past few years have been tuberculosis, cryptococcal meningitis and HIV in the public health context. In my previous roles, I have been involved in phase IIa, IIb and clinical trials investigating novel anti-tuberculosis and anti-cryptococcosis drugs and regimens. It has also been my responsibility to engage with local health authorities to integrate clinical trials into programmatic practice. In my current position, I am a site Principal Investigator (UCT) on the EFFECT clinical trial of a novel regimen for treatment of cryptococcal antigenaemia with a view to reducing progression to cryptococcal meningitis, and I am the study's Trial Clinician, overseeing clinical conduct at 11 sites in 2 sub-Saharan African countries (South Africa and Tanzania). I also sit on the AMNET (African Meningitis Trials Network) steering committee. I have recently completed an MSc in Infectious Diseases from the London School of Hygiene and Tropical Medicine with merit.